Exodus Point Capital Management, LP Harmony Biosciences Holdings, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 23,686 shares of HRMY stock, worth $781,638. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,686Holding current value
$781,638% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding HRMY
# of Institutions
240Shares Held
45.2MCall Options Held
103KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$370 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$193 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$115 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$86 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$63.6 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.95B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...